In the wake of patient death, Sutro says its Chinese partner is rethinking their deal and withholding $40M
A little over two months after brandishing a China deal — its first major pact since teaming up with Merck in 2018 — featuring …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
